UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G/A

Under the Securities Exchange Act of 1934
(Amendment No. )*

First Trust NASDAQ Pharmaceuticals ETF

33738R837

March 31, 2023

Check the appropriate box to designate the rule pursuant to which this
Schedule is filed:

[X]  Rule 13d-1 (b)
[ ]  Rule 13d-1 (c)
[ ]  Rule 13d-1 (d)

*The remainder of this cover page shall be filled out for a reporting
person's initial filing on this form with respect to the subject class
of securities, and for any subsequent amendment containing information
which would alter the disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not
be deemed to be "filed" for the purpose of Section 18 of the Securities
Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of
that section of the Act but shall be subject to all other provisions of
the Act (however, see the Notes).


CUSIP No.  33738R837
1. Names of Reporting Persons.
I.R.S. Identification Nos. of above persons

Truist Financial Corporation as Parent Holding Company for
Truist Advisory Services, Inc. an affiliated registered
investment advisor.
56-0939887

2. Check the Appropriate Box if a Member of a Group
(a) __________
(b) __________

3. SEC Use Only

4. Citizenship or Place of Organization
North Carolina


Number of	5.  Sole Voting Power	                 45,988.
Shares
Beneficially	6.  Shared Voting Power		              0.
Owned by
Each		7.  Sole Dispositive Power               45,988.
Reporting
Person With	8.  Shared Dispositive Power	              0.

9. Aggregate Amount Beneficially Owned by Each Reporting Person
	  45,988.

10. Check if the Aggregate Amount in Row (9) Excludes Certain Shares*

11.  Percent of Class Represented by Amount in Row (9)
	3.679%

12.  Type of Reporting Person*
	HC / IA




UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G/A

Under the Securities Exchange Act of 1934


Item 1.
(a) Name of Issuer:
First Trust Exchange-Traded Fund VI
(b) Address of Issuer's Principal Executive Offices:
120 East Liberty Drive, Suite 400
Wheaton, IL 60187


Item 2.
(a) Name of Person Filing:
Truist Financial Corporation as Parent Holding Company for
Truist Advisory Services, Inc. an affiliated Registered
Investment advisor.
(b) Address of Principal Business Office or, if none, Residence:
214 North Tryon Street
Charolotte, NC 28202
(c) Citizenship:
Truist Financial Corporation is a North Carolina Corporation;
Truist Advisory Services, Inc. is a Delaware Corporation.
(d) Title of Class of Securities:
Exchange Traded Fund
(e) CUSIP Number
33738R837

Item 3.	If this statement is filed pursuant to SS240.13d-1(b) or
240.13-2(b) or (c), check whether the person filing is a:

(a) [ ]	Broker or dealer registered under section 15 of the Act
(15 U.S.C. 78o);
(b) [ ]	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c) [ ]	Insurance company as defined in section 3(a)(19) of the Act
(15 U.S.C. 78c);
(d) [ ]	Investment company registered under section 8 of the Investment
Company Act of 1940 (15 U.S.C. 80a-8);
(e) [X]	An investment adviser in accordance with
SS240.13d-1(b)(1)(ii)(E);
(f) [ ]	An employee benefit plan or endowment fund in accordance with
SS240.13d-1(b)(1)(ii)(F);
(g) [X]	A parent holding company or control person in accordance with
SS240.13d-1(b)(1)(ii)(G);
(h) [ ]	A savings association as defined in Section 3(b) of the Federal
Deposit Insurance Act (12 U.S.C. 1813);
(i) [ ]	A church plan that is excluded from the definition of an
investment company under section 3(c)(14) of the Investment Company Act
of 1940 (15 U.S.C. 80a-3);
(j) [ ]	Group, in accordance with SS240.13d-1(b)(1)(ii)(J).

Item 4.	Ownership

Provide the following information regarding the aggregate number and
percentage of the class of securities of the issuer identified in
Item 1.

(a) Amount beneficially owned:			     	         45,988.
(b) Percent of class:				                 3.679%.
(c) Number of shares as to which the person has:
(i) Sole power to vote or to direct the vote		         45,988.
(ii) Shared power to vote or to direct the vote		              0.
(iii) Sole power to dispose or to direct the disposition of      45,988.
(iv) Shared power to dispose or to direct the disposition of          0.

Item 5.	Ownership of Five Percent or Less of a Class
If this statement is being filed to report the fact that as of the date
hereof the reporting person has ceased to be the beneficial owner of
more than five percent of the class of securities, check the following
[X].

Item 6.	Ownership of More than Five Percent on Behalf of Another Person
Various co-trustees may share the power to direct the receipt of income
including dividends as well as the proceeds from sale of securities.

Item 7.	Identification and Classification of the Subsidiary Which
Acquired the Security Being Reported on By the Parent Holding Company
Not applicable

Item 8.	Identification and Classification of Members of the Group
Not Applicable

Item 9.	Notice of Dissolution of Group
Not Applicable

Item 10. Certification
By signing below I certify that, to the best of my knowledge and belief,
the securities referred to above were acquired and are held in the
ordinary course of business and were not acquired and are not held for
the purpose of or with the effect of changing or influencing the control
of the issuer of the securities and were not acquired and are not held
in connection with or as a participant in any transaction having that
purpose or effect.


SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true,
complete and correct.

April 10, 2023
Date

/s/  Robert R Magill
Signature
Robert R Magill / Vice President
Name / Title








Truist Financial Corporation
214 North Tryon Street
Charlotte, NC 28292

April 10, 2023

Ladies and Gentlemen:

There is hereby transmitted for filing pursuant to Section 13(g) of the
Securities and Exchange Act of 1934 and Rule 13G thereunder a Schedule
13G relating to beneficial ownership by Truist Financial Corporation
and its subsidiaries of shares of First Trust NASDAQ Pharmaceuticals ETF.

Please call the undersigned at (252) 246-2190 if you have any questions.

Sincerely,


/s/  Robert R Magill
Vice President